Paul C Avey Popular Books

Paul C Avey Biography & Facts

Linda Avey (née Bahnson) is an American biologist and entrepreneur. She is known for co-founding 23andMe, a consumer genetic data company. Early life Avey was born Linda Bahnson in 1960, in South Dakota, United States. She attended Augustana University, where she received a Bachelor of Arts in biology, in 1982. Early career Avey began her scientific career in 1982 at University of California, Irvine as a staff research associate. It has been stated that in 1985, she moved into various sales and business development in the fields of biopharmaceutical and academic research. As of 2024, a site to which Avey submits information was stating that she had "over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C." She has stated that she worked for Perlegen Sciences and for Affymetrix "develop[ing] translational research collaborations with academic and pharmaceutical partners".She also held positions at Spotfire, Chemdex, Applied Biosystems, PerSeptive Biosystems, Molecular Dynamics, and Waters Corporation. 23andMe and later career In March 2006 Avey, Anne Wojcicki, and Paul Cusenza founded 23andMe, "one of the first, and only, companies to offer genetic profiles directly to consumers, rather than through doctors or researchers". Avey left the company in 2009. Cusenza had left the company in 2007.In 2009, Avey launched the Brainstorm Research Foundation, to "creat[e] an outsourced potential to do research" with "initial focus is on Alzheimer's disease" to "creat[e] novel cohorts and collec[t]... phenotypic information". In 2011, Avey co-founded We are Curious, Inc. with Heather Anne Halpert and Mitsu Hadeishi, a company focused on online aggregation of data from sensors, wearables, trackers, apps, social media, biometrics, and other personal data. In 2018, Avey and Aneil Mallavarapu began collaboration with Naryana Health to focus on collecting and analyzing genetic information from populations often economically excluded, via their further start-up, Precisely, Inc.Avey is an advisor to Verily Life Sciences and is on the Board of Fellows at Stanford Medical School. In November of 2023, Avey joined the Board of Directors of the Human Immunome Project (HIP). References Further reading Pitts, Peter (February 15, 2017). "Capital Flows: The Privacy Delusions Of Genetic Testing". Forbes.com. Retrieved February 5, 2024. An article referring to Avery and 23andMe regarding the limited data protection offered to her company's clients. Herper, Matthew (June 13, 2013). "For 23andMe, The Real Value Could Be In Its Data". Forbes.com. Retrieved July 20, 2018. Farr, Christina (June 1, 2018). "Alphabet's Verily Has Hired Top Execs to Bring its Science Research into Hospitals and Homes". CNBC.com. Retrieved February 5, 2024. Naming of Avey to the board of Verily. Singer, Emily; Avey, Linda; Wojcicki, Anne (October 20, 2008). "Linda Avey and Anne Wojcicki: The Founders of Startup 23andMe Want to Know Your Genome" (Interview). MIT Technology Review. Retrieved July 20, 2018. Interview with two of the founders.External links Biographical information on Paul Cusenza, one of Avery's co-founders at 23andMe. New Yorker Video Interview with two of three 23andMe co-founders, Avey and Wojcicki.. Discover the Paul C Avey popular books. Find the top 100 most popular Paul C Avey books.